DFX Intelligence

Data Factory

Private equityFirmbuyoutmiddle market

Gurnet Point Capital, LLC

Private Equity

Cambridge, MA

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:bfe665d3-0738-4a9a-8b02-edf2593011d5

Data as of Sep 15, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures, news and newswire. Page built Sep 19, 2026, 5:54 PM UTC and rebuilt at most every 15 minutes.

Relationships: 31
Dated events: 40
On other graphs: 1
Observed: Sep 13, 2026 to Sep 15, 2026
25 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

RIA / Wealth Managementidentity

GURNET POINT CAPITAL, LLC

Registered adviser · shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 6
PE funds: 6
Regulatory AUM: $3.2B
Investments: 5
Active investments: 4
Size band: MIDDLE MARKETderivedproxy: $3.57bn Private Equity Fund GAV on the Form ADV filed 2023-09-29
Latest ADV filing: Sep 29, 2023
Employees (ADV): 17
Website: gurnetpointcapital.com

Funds

Fund	Vintage	Lifecycle	ADV type	Form D sold	GAV
Gurnet Point II L.P.	n/a	Unknown	Private Equity Fund	n/a	$0
Gurnet Point LP	n/a	Unknown	Private Equity Fund	n/a	$2.4B
GPC Wh Fund LP	n/a	Unknown	Private Equity Fund	n/a	$516M
GPC Ginger Aggregator LP	n/a	Unknown	Private Equity Fund	n/a	$235M
GPC Resistance Aggregator GP LLC	n/a	Unknown	Private Equity Fund	n/a	$257M
Gurnet Point Nspv LP	n/a	Unknown	Private Equity Fund	n/a	$157M

Investments

Company	State	Role	Control	Invested	Exited	Status
Remaining 57% Interest	n/a	platform	control	Jan 12, 2026	n/a	active
Remaining 57% Interest	n/a	platform	control	Jan 12, 2026	n/a	active
Paratek Pharmaceuticals	n/a	platform	control	Jun 6, 2023	n/a	active
Corium International	n/a	platform	control	Nov 27, 2018	n/a	active
Affidea Group	n/a	unknown	unknown	n/a	Apr 19, 2022	exited

Relationships

Invested in (4)

→ Remaining 57% InterestCompanyplatform
Jan 12, 2026 to presentfactNews and newswire
→ Corium InternationalCompanyplatform
Nov 27, 2018 to presentfactNews and newswire
→ Paratek PharmaceuticalsCompanyplatform
Jun 6, 2023 to presentfactNews and newswire
→ Affidea GroupCompanyunknown
factNews and newswire

Employs (12)

→ Nithya DesikanPersonOperating Partner
factNews and newswire
→ Christopher ViehbacherPersonManaging Partner
factNews and newswire
→ Stacey SeltzerPersonPartner
Oct 1, 2022 to presentfactForm ADV, News and newswire
→ Stefan MeisterPersonVice-Chairman
factNews and newswire
→ Oliver HeatonPersonManaging Director, Group Investments
factThe subject's own site
→ Sarah CrawfordPersonGroup CFO, Partner and Member of the Board
factThe subject's own site
→ Ernesto Silvio Maurizio BertarelliPersonOwner
Aug 1, 2023 to presentfactForm ADV, The subject's own site
→ Ranjani KearsleyPersonHead of Asset Management Investments
factThe subject's own site
→ Peter AgnesPersonOperating Partner, B-Flexion Life Sciences
factThe subject's own site
→ Steven RotmanPersonOperating Partner, B-Flexion Life Sciences
factThe subject's own site
→ Travis WilsonPersonPartner
Nov 1, 2015 to presentfactForm ADV
→ Adam DilluvioPersonChief Compliance Officer, General Counsel
May 1, 2019 to presentfactForm ADV

Firm member (1)

→ B-FlexionFirmAnchor adviser
factDFX's own graph

Manages (6)

→ GPC Resistance Aggregator GP LLCFundPrivate Equity Fund
Sep 29, 2023 to presentfactForm ADV
→ Gurnet Point LPFundPrivate Equity Fund
Sep 29, 2023 to presentfactForm ADV
→ Gurnet Point II L.P.FundPrivate Equity Fund
Sep 29, 2023 to presentfactForm ADV
→ GPC Ginger Aggregator LPFundPrivate Equity Fund
Sep 29, 2023 to presentfactForm ADV
→ GPC Wh Fund LPFundPrivate Equity Fund
Sep 29, 2023 to presentfactForm ADV
→ Gurnet Point Nspv LPFundPrivate Equity Fund
Sep 29, 2023 to presentfactForm ADV

Owns (4)

← Gurnet Point Capital Holdco LLCFirmSole Shareholder
Aug 1, 2023 to presentfactForm ADV
← B-Flexion Services (US) IncFirmSole Shareholder Of Gurnet Point Capital Holdco Llc
Aug 1, 2023 to presentfactForm ADV
← B-Flexion International Holdings SaFirmSole Shareholder Of B-Flexion Services (Us) Inc
Oct 1, 2012 to presentfactForm ADV
← B-Flexion Group Holdings SaFirmSole Shareholder Of B-Flexion International Holdings Sa
Jun 1, 2017 to presentfactForm ADV

Dated events

7 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Apr 29, 2026
Firm news
CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing Wed, 04/29/2026 - 16:47
The subject's own siteobserved 4 days ago
Occurred
Mar 18, 2026
Firm news
Paratek Pharmaceuticals Completes Combination with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform Wed, 03/18/2026 - 15:28
The subject's own siteobserved 4 days ago
Occurred
Jan 12, 2026
Firm news
B-FLEXION Life Sciences to Acquire Remaining 57% Interest in Radius Health Mon, 01/12/2026 - 16:55
The subject's own siteobserved 4 days ago
Occurred
Jan 12, 2026
Platform investment
B-FLEXION Life Sciences to Acquire Remaining 57% Interest in Radius Health Mon, 01/12/2026 - 16:55
Remaining 57% Interest News and newswireobserved 4 days ago
Occurred
Jan 12, 2026
Transaction announced
B-FLEXION Life Sciences to Acquire Remaining 57% Interest in Radius Health Mon, 01/12/2026 - 16:55
News and newswireobserved 4 days ago
Occurred
May 23, 2025
Firm news
Crosstree Real Estate Partners Acquires Argyll, London's Premier Serviced Office Provider Fri, 05/23/2025 - 12:57
The subject's own siteobserved 4 days ago
Occurred
May 21, 2025
Firm news
Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies Wed, 05/21/2025 - 13:48
The subject's own siteobserved 4 days ago
Occurred
May 14, 2025
Firm news
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD) Wed, 05/14/2025 - 10:58
The subject's own siteobserved 4 days ago
Occurred
Mar 20, 2025
Firm news
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS) Thu, 03/20/2025 - 09:34
The subject's own siteobserved 4 days ago
Occurred
Jul 25, 2024
Firm news
Twelve Capital and Securis announce merger to create a leader in Insurance-Linked Securities (ILS) Thu, 07/25/2024 - 11:21
The subject's own siteobserved 4 days ago
Occurred
Oct 3, 2023
Firm news
Allergy Partners Announces Acquisition of Charleston Allergy and Asthma Tue, 10/03/2023 - 14:50
The subject's own siteobserved 4 days ago
Occurred
Sep 29, 2023
Adviser first adv filing
Gurnet Point Capital, LLC first filed Form ADV in the extract (IA)
Form ADVobserved 5 days ago
Occurred
Sep 18, 2023
Firm news
Allergy Partners Appoints Chris Kane as Chief Executive Officer Mon, 09/18/2023 - 15:55
The subject's own siteobserved 4 days ago
Occurred
Jun 7, 2023
Firm news
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings Wed, 06/07/2023 - 08:10
The subject's own siteobserved 4 days ago
Occurred
Jun 6, 2023
Platform investment
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings Wed, 06/07/2023 - 08:10
Paratek Pharmaceuticals News and newswireobserved 4 days ago
Occurred
Jun 6, 2023
Transaction announced
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings Wed, 06/07/2023 - 08:10
News and newswireobserved 4 days ago
Occurred
Jan 26, 2023
Firm news
GPC's Innocoll Holdings Ltd. Appoints Kimball Hall as Chief Executive Officer Thu, 01/26/2023 - 16:20
The subject's own siteobserved 4 days ago
Occurred
Oct 21, 2022
Firm news
Corium and Gurnet Point Capital Announce Manufacturing Business Acquisition and a $100 Million Neuroscience Therapeutics Investment by Webster Equity Partners Fri, 10/21/2022 - 12:17
The subject's own siteobserved 4 days ago
Occurred
Sep 28, 2022
Firm news
Capital Four's Private Debt III Fund closes above target and at hard cap of €1.5 billion Wed, 09/28/2022 - 16:28
The subject's own siteobserved 4 days ago
Occurred
Sep 13, 2022
Firm news
Allergy Partners joins Consortium of Independent Immunology Clinics (CIIC) Tue, 09/13/2022 - 15:23
The subject's own siteobserved 4 days ago
Occurred
Jun 23, 2022
Firm news
Radius Health Announces Agreement to be Acquired by Gurnet Point Capital and Patient Square Capital Thu, 06/23/2022 - 15:37
The subject's own siteobserved 4 days ago
Occurred
May 24, 2022
Firm news
Peter Sanborn Joins Arbor Ventures as General Partner; will lead Arbor B-FLEXION Growth Fund Tue, 05/24/2022 - 14:37
The subject's own siteobserved 4 days ago
Occurred
May 10, 2022
Firm news
Boston Pharmaceuticals Appoints Dr. Sophie Kornowski as Chair of its Board of Directors and Acting Chief Executive Tue, 05/10/2022 - 15:59
The subject's own siteobserved 4 days ago
Occurred
Apr 19, 2022
Firm news
B-FLEXION Sells Affidea Group to GBL Tue, 04/19/2022 - 08:00
The subject's own siteobserved 4 days ago
Occurred
Apr 19, 2022
Exit
B-FLEXION Sells Affidea Group to GBL Tue, 04/19/2022 - 08:00
Affidea Group News and newswireobserved 4 days ago
Occurred
Apr 19, 2022
Transaction announced
B-FLEXION Sells Affidea Group to GBL Tue, 04/19/2022 - 08:00
News and newswireobserved 4 days ago
Occurred
Feb 22, 2022
Firm news
Forestay Invests Again in Zenjob Tue, 02/22/2022 - 09:53
The subject's own siteobserved 4 days ago
Occurred
Feb 9, 2022
Firm news
Forestay investment, Scandit, goes Unicorn with Series D Wed, 02/09/2022 - 15:43
The subject's own siteobserved 4 days ago
Occurred
Feb 3, 2022
Firm news
Forestay portfolio investment, BlueBotics, acquired by ZAPI Thu, 02/03/2022 - 10:54
The subject's own siteobserved 4 days ago
Occurred
Dec 23, 2021
Firm news
Waypoint Capital Acquires Majority Stake in Allergy Partners Thu, 12/23/2021 - 14:56
The subject's own siteobserved 4 days ago
Occurred
Jan 8, 2020
Firm news
Waypoint Capital Appoints Elias Zerhouni to Board of Directors Wed, 01/08/2020 - 13:19
The subject's own siteobserved 4 days ago
Occurred
Sep 26, 2019
Firm news
GPC's Portfolio Investment, Before Brands, Secures Backing from Nestle Health Science Thu, 09/26/2019 - 12:57
The subject's own siteobserved 4 days ago
Occurred
Sep 23, 2019
Firm news
Forestay Capital Invests in Kandou, a global leader in connectivity IP and chip solutions Mon, 09/23/2019 - 11:20
The subject's own siteobserved 4 days ago

Show 7 bookkeeping events

Occurred
Sep 1, 2026
Adviser CRD 320759 is not on the SEC registered or exempt adviser roster of 2026-09-01
Occurred
Sep 29, 2023
Gurnet Point LP first reported on Form ADV by Gurnet Point Capital, LLC (Private Equity Fund), GAV $2,404,012,294
Occurred
Sep 29, 2023
Gurnet Point II L.P. first reported on Form ADV by Gurnet Point Capital, LLC (Private Equity Fund)
Occurred
Sep 29, 2023
GPC Ginger Aggregator LP first reported on Form ADV by Gurnet Point Capital, LLC (Private Equity Fund), GAV $234,852,685
Occurred
Sep 29, 2023
GPC Wh Fund LP first reported on Form ADV by Gurnet Point Capital, LLC (Private Equity Fund), GAV $515,829,123
Occurred
Sep 29, 2023
GPC Resistance Aggregator GP LLC first reported on Form ADV by Gurnet Point Capital, LLC (Private Equity Fund), GAV $257,037,883
Occurred
Sep 29, 2023
Gurnet Point Nspv LP first reported on Form ADV by Gurnet Point Capital, LLC (Private Equity Fund), GAV $156,778,365

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 office address (Form ADV), 1 website (Form ADV) · as of 2026-09-13

Oliver Heaton
Managing Director, Group Investments · Revealable: 1 professional profile (firm website)
Sarah Crawford
Group CFO, Partner and Member of the Board · Revealable: 1 professional profile (firm website)
Ernesto Silvio Maurizio Bertarelli
Owner · Revealable: 2 professional profiles (firm website)
Ranjani Kearsley
Head of Asset Management Investments · Revealable: 1 professional profile (firm website)
Peter Agnes
Operating Partner, B-Flexion Life Sciences · Revealable: 1 professional profile (firm website)
Steven Rotman
Operating Partner, B-Flexion Life Sciences · Revealable: 1 professional profile (firm website)

Also named here, with no published line of their own (reach them through the firm): Nithya Desikan (Operating Partner), Christopher Viehbacher (Managing Partner), Stacey Seltzer (Partner), Stefan Meister (Vice-Chairman), Travis Wilson (Partner), Adam Dilluvio (Chief Compliance Officer, General Counsel).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Private Equity
Canonical id: dfx:pe:bfe665d3-0738-4a9a-8b02-edf2593011d5
First observed: Sep 13, 2026
Last observed: Sep 15, 2026 4 days ago
Source families: Federal regulator filings, Firm and issuer disclosures, News and newswire
4 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Gurnet Point Capital, LLC

Private Equity

Cambridge, MA

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:bfe665d3-0738-4a9a-8b02-edf2593011d5

Fund

Vintage

Lifecycle

ADV type

Form D sold

GAV

LPs

Gurnet Point II L.P.

n/a

Unknown

Private Equity Fund

n/a

Gurnet Point LP

n/a

Unknown

Private Equity Fund

n/a

$2.4B

GPC Wh Fund LP

n/a

Unknown

Private Equity Fund

n/a

$516M

GPC Ginger Aggregator LP

n/a

Unknown

Private Equity Fund

n/a

$235M

GPC Resistance Aggregator GP LLC

n/a

Unknown

Private Equity Fund

n/a

$257M

Gurnet Point Nspv LP

n/a

Unknown

Private Equity Fund

n/a

$157M

Company

State

Role

Control

Invested

Exited

Status

Remaining 57% Interest

n/a

platform

control

Jan 12, 2026

n/a

active

Remaining 57% Interest

n/a

platform

control

Jan 12, 2026

n/a

active

Paratek Pharmaceuticals

n/a

platform

control

Jun 6, 2023

n/a

active

Corium International

n/a

platform

control

Nov 27, 2018

n/a

active

Affidea Group

n/a

unknown

n/a

Apr 19, 2022

exited